Relieved Type 2 Diabetes (T2D) By Petite Low Carbohydrate Diet (LCD), Equmet and Twymeeg

Bando H, Iwatsuki N, Okada M, Ogawa T and Sakamoto K

Published on: 2024-08-31

Abstract

The case is 53-year-old female with Type 2 diabetes (T2D). She felt thirsty, polydipsia, polyuria from April 2023, and was diagnosed as T2D in June 2023 with HbA1c 13.7%. She began petite Low Carbohydrate Diet (LCD) and continued the diet therapy. She took metformin and vildagliptin (EquMet) resulting HbA1c 7.9% in October 2023. She added imeglimin (Twymeeg) and Empagliflozin (Jardiance) resulting HbA1c 6.9% in August 2024. Pulse wave velocity (PWV) showed ankle brachial index?ABI?1.09, cardio-ankle vascular index (CAVI) 10.7, indicating arteriosclerosis. Consequently, clinical progress seems to be satisfactory with efficacy of LCD, EquMet, Twymeeg and Empagliflozin.